ARDX241101P5000
- 0.13
- +0.01+8.33%
Ardelyx Newsroom
Ardelyx Beats Q3 Sales Estimates, Shares Climb
12 Health Care Stocks Moving In Thursday's After-Market Session
Express News | Ardelyx Inc Q3 Shr View $-0.05 -- LSEG IBES Data
Express News | Ardelyx : Extended Interest-Only Period for Existing and New Tranches Funded Under Instrument to July 1, 2028
Express News | Ardelyx : Drew $50 Mln at Sofr Plus 4.02% in Oct 2024, Added Opportunity to Draw an Additional $50 Mln at Same Interest Rate
Express News | Ardelyx : Amended Its February 2022 Loan Agreement With Investment Affiliates Managed by SLR Capital Partners (SLR)
Ardelyx | 10-Q: Quarterly report
Earnings Flash (ARDX) ARDELYX Reports Q3 Revenue $98.2M
Ardelyx: XPHOZAH Generates $51.5 M in Net Pdt Sales Rev >ARDX
Express News | Ardelyx Shares Rise 6.0% After the Bell Following Results
Ardelyx Ends 3Q With Approximately $190 M in Cash, Cash Equivalents and Investments >ARDX
Express News | Ardelyx Q3 Net Income USD -809 Thousand
Express News | Ardelyx Q3 Operating Expenses USD 80.28 Million
Express News | Ardelyx Q3 Operating Income USD 2.233 Million
Express News | Ardelyx Q3 Product Sales USD 92.09 Million
Press Release: Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update
Ardelyx 3Q EPS 0c >ARDX
Here Are the Major Earnings After the Close Today
Ardelyx's Earnings Outlook
Ardelyx Presents Results From Its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology's (ACG) Annual Meeting